A detailed history of Wellington Management Group LLP transactions in Savara Inc stock. As of the latest transaction made, Wellington Management Group LLP holds 7,015,490 shares of SVRA stock, worth $26.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
7,015,490
Previous 2,779,186 152.43%
Holding current value
$26.8 Million
Previous $13.8 Million 104.28%
% of portfolio
0.01%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$3.66 - $5.34 $15.5 Million - $22.6 Million
4,236,304 Added 152.43%
7,015,490 $28.3 Million
Q1 2024

May 15, 2024

BUY
$4.19 - $5.59 $11.6 Million - $15.5 Million
2,779,186 New
2,779,186 $13.8 Million
Q4 2023

Feb 12, 2024

BUY
$3.18 - $4.9 $6.55 Million - $10.1 Million
2,060,173 New
2,060,173 $9.68 Million

Others Institutions Holding SVRA

About Savara Inc


  • Ticker SVRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 114,043,000
  • Market Cap $436M
  • Description
  • Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.
More about SVRA
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.